Malondialdehyde HPLC (MDA HPLC)

$449.00
Catalog
30-1900
The MDA HPLC assay is intended for the quantitative determination of malondialdehyde in plasma, serum and urine. For Research Use Only. Not for use in diagnostic procedures.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available in North America Only
Range
n/a
Sensitivity
0.15 nmol/L
Sizes
100 Tests
Sample Types
Plasma, Serum, Urine
Inc Time Hour
1
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
20
In the last years the damage effects of lipid peroxidation products were studied intensively. These are formed when free radicals will overcome the radical-trapping-mechanisms of the body and reacting with unsaturated fatty acids. The reaction of polyunsaturated fatty acids (PUFA´s) with activated oxygen species results in lipidhydroperoxides (primary lipid peroxidation products) which were degraded to secundary lipid peroxidation products like alkanes (e.g. ethane and pentane), aliphatic aldehydes (e.g. malondialdehyde [MDA] and 4-hydroxynonenale [4-HNE]). Primary and secondary lipid peroxidation products have an influence on a lot of molecules responsible for correct cell function. So lipidhydroperoxides easily pass the nuclear membrane and can react with nucleic acids. Also proteins can be attacked on their thiol groups changing their stereochemistry and function. Moreover lipidhyroperoxides interfere with chemical and physical properties of the cell membrane. The fluidity decreases and rigidity increases. The so influenced cell membrane can´t maintain their barrier function and intracellular potassium ions leake out as well as intracellulary enzymes are lost. If erythrocytes are afflicted haemolysis takes place. In this case haemoglobin can initiate or propagate the lipid peroxidation. Secondary lipid peroxidation products like MDA or 4-HNE can react with DNA as well, in particular with the bases guanin and adenin. These DNA aberrations lead to errorneous transcriptions and therewith to altered gen products. Peptide bonds are broken through the impact of MDA in proteins. Aldehydes react with amino groups of proteins building Schiff-bases, elementary disturbing correct function of proteins. All these toxical features of oxidized fatty acids are discussed in the pathogeneses of many diseases and dysfunction of organs. In particular arteriosclerosis, tumor diseases, rheumatic diseases and reperfusion damage of organs after ischemic processes.

Malondialdehyde HPLC (MDA HPLC)

30-1900

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
Salem, NH, December 19, 2023 – Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the...
View Now
Targeted Solutions for Gastroenterology
Targeted Solutions for Gastroenterology
ALPCO offers targeted GI solutions suitable for all types of labs. Our offerings range from plate-based to clinical chemistry analyzer-based and automated flash chemiluminescence solutions, all designed to accommodate your lab’s expanding testing needs and capabilities.
View Now
 Optimizing IBD Management with Fecal Calprotectin: From Diagnosis to Monitoring
Live Webinar: Optimizing IBD Management with Fecal Calprotectin - From Diagnosis to Monitoring
In the webinar, Dr. Benjamin Click from the University of Colorado, Department of Gastroenterology, underscores the critical role of non-invasive monitoring methods, particularly fecal calprotectin monitoring, in guiding treatment adjustments and achieving therapeutic goals..
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.